Genotypic and Phenotypic Characterization of Replication-Competent HIV-2 Isolated from Controllers and Progressors by Cynthia Lungu, Ronald J. Overmars, Esmée Grundeken, Patrick H. M. Boers, Marchina E. van der Ende, Thibault Mesplède, Rob A. Gruters

Get full text

Preconception use of cART by HIV-positive pregnant women increases the risk of infants being born small for gestational age. by Ingrid J M Snijdewind, Colette Smit, Mieke H Godfried, Rachel Bakker, Jeannine F J B Nellen, Vincent W V Jaddoe, Elisabeth van Leeuwen, Peter Reiss, Eric A P Steegers, Marchina E van der Ende

Get full text

No treatment versus 24 or 60 weeks of antiretroviral treatment during primary HIV infection: the randomized Primo-SHM trial. by Marlous L Grijsen, Radjin Steingrover, Ferdinand W N M Wit, Suzanne Jurriaans, Annelies Verbon, Kees Brinkman, Marchina E van der Ende, Robin Soetekouw, Frank de Wolf, Joep M A Lange, Hanneke Schuitemaker, Jan M Prins, Primo-SHM Study Group

Get full text

von Willebrand Factor is elevated in HIV patients with a history of thrombosis by Lennert W.J. van den Dries, Rob A. Gruters, Sascha B.C. Hövels – van der Borden, Marieke J.H.A. Kruip, Moniek ede Maat, Eric C.M. van Gorp, Eric C.M. van Gorp, Marchina E. van der Ende

Get full text

Immune reconstitution inflammatory syndrome in HIV infected late presenters starting integrase inhibitor containing antiretroviral therapy by Ingeborg E.A. Wijting, Ferdinand W.N.M. Wit, Casper Rokx, Eliane M.S. Leyten, Selwyn H. Lowe, Kees Brinkman, Wouter F.W. Bierman, Marjo E.E. van Kasteren, Anneloes M. Postma, Vera C.M. Bloemen, Ghariba Bouchtoubi, Andy I.M. Hoepelman, Marchina E. van der Ende, Peter Reiss, Bart J.A. Rijnders

Get full text